SCHEMBL24993560

SCHEMBL24993560

CCOc1ccc(-c2cnc(CC)c(C(=O)NN)n2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.54
▸ MAPT P10636 5/20 0.49
▸ NPC1 O15118 5/20 0.48
▸ KDM4E B2RXH2 3/20 0.48
▸ SCN2A Q99250 3/20 0.47
▸ SCN10A Q9Y5Y9 3/20 0.47
▸ ADORA3 P0DMS8 1/20 0.44
▸ RAB9A P51151 5/20 0.44
▸ ATR Q13535 2/20 0.43
▸ PRKDC P78527 1/20 0.43
▸ POLB P06746 1/20 0.42
▸ ALPL P05186 1/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ TP53 P04637 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ ACVR1 Q04771 1/20 0.41
▸ PLK1 P53350 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24993561 0.86 ALDH1A1 (0.55) ALDH1A1MAPTNPC1KDM4ESCN2A
SCHEMBL24994737 0.86 NPC1 (0.52) ALDH1A1MAPTNPC1KDM4ESCN2A
SCHEMBL24993559 0.84 ALDH1A1 (0.53) ALDH1A1MAPTNPC1KDM4ESCN2A
SCHEMBL24993563 0.82 MAPT (0.51) ALDH1A1MAPTNPC1KDM4ESCN2A
SCHEMBL24993566 0.80 ALDH1A1 (0.49) ALDH1A1MAPTNPC1KDM4ESCN2A
SCHEMBL24993367 0.78 ALDH1A1 (0.55) ALDH1A1MAPTNPC1KDM4ESCN2A
SCHEMBL3461301 0.78 ATR (0.57) ATRPRKDCACVR1PLK1
SCHEMBL24993306 0.77 SCN10A (0.69) ALDH1A1MAPTNPC1KDM4ESCN2A
SCHEMBL3463016 0.75 MAPT (0.51) ALDH1A1MAPTNPC1KDM4ESCN2A
SCHEMBL24993600 0.74 NPC1 (0.53) ALDH1A1MAPTNPC1KDM4ESCN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023010191-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS EUROFARMA LABORATÓRIOS S.A. (BR) 2023-02-09 — — WO disclosed
Send feedback